LPT-99

DB17142ExperimentalSmall molecule

LPT-99: Overview.

Mechanism: Pharmacologically active on Apoptotic protease-activating factor 1
Curator reviewed
Formula / weight: C₃₁H₃₂Cl₂N₄O₄S · 627.58 g/mol (avg)
Also known as: 2-(4-(2,4-dichlorophenethyl)-3,6-dioxo-1-(2-(thiophen-2-yl)ethyl)piperazin-2-yl)-n-(2-(5-methoxy-1h-indol-3-yl)ethyl) acetamide · 2-(4-(2,4-dichlorophenethyl)-3,6-dioxo-1-(2-(thiophen-2-yl)ethyl)piperazin-2-yl)-n-(2-(5-methoxy-1h-indol-3-yl)ethyl)acetamide · 2-piperazineacetamide, 4-(2-(2,4-dichlorophenyl)ethyl)-n-(2-(5-methoxy-1h-indol-3-yl)ethyl)-3,6-dioxo-1-(2-(2-thienyl)ethyl)-
Code names: LPT-99

Resolves to

Compound

Structure

InChIKeyXLXXBYJYWULGGD-UHFFFAOYSA-NSMILESCOC1=CC2=C(NC=C2CCNC(=O)CC2N(CCC3=CC=CS3)C(=O)CN(CCC3=CC=C(Cl)C=C3Cl)C2=O)C=C1

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with LPT-99, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.